H-1B sponsorship profile: Gland Pharma USA Inc. Across U.S. Department of Labor LCA disclosures, Gland Pharma USA Inc filed 1 Labor Condition Applications covering 1 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 100% (1 certified of 1 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Gland Pharma USA Inc’s H-1B petitions range from $148,000 at the low end to $148,000 at the high end, with a petition-weighted average of $148,000. That range reflects the mix of occupations the company sponsors, led by Associate Director - Commercial/Strategic Partnerships (1 petitions at $148,000 avg). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Gland Pharma USA Inc is headquartered in Princeton, NJ under NAICS code 424210, and places H-1B workers across 1 state, most heavily in NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Gland Pharma USA Inc ranks. By H-1B petition volume, Gland Pharma USA Inc is #72,571 of 119,880 employers nationally and #3,948 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.